TransMedics Group, Inc. TMDX
TransMedics Group, Inc. statistics & valuation
Market cap$2.4B
P / E12.4×
P / S3.9×
P / B5.0×
P / FCF17.7×
Net margin31.4%
Return on equity40.2%
FCF margin22.1%
Return on capital11.1%
Graham number -58.9%$35.76
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($35.76); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 59.9% | 59.4% | 63.8% | 69.8% | 67.4% | 58.7% | 53.6% | 39.1% |
| Operating margin | 17.9% | 8.5% | -11.9% | -33.6% | -125.6% | -93.0% | -114.5% | -138.1% |
| Net margin | 31.4% | 8.0% | -10.4% | -38.8% | -140.9% | -101.4% | -129.8% | -162.1% |
| FCF margin | 22.1% | -18.3% | -68.2% | -61.8% | -103.2% | -108.3% | -125.6% | -180.1% |
| Return on assets | 17.8% | 4.4% | -3.5% | -13.1% | -32.8% | -18.9% | -31.9% | -56.4% |
| Return on equity | 40.2% | 15.5% | -18.2% | -19.3% | -65.2% | -27.7% | -61.4% | 12.4% |
| Debt / equity | — | — | — | 0.31× | 0.52× | 0.33× | 0.62× | -0.18× |
| Current ratio | 7.14 | 8.30 | 9.30 | 10.66 | 5.11 | 12.36 | 6.21 | 2.77 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.